allergic rhinitis
Conditions
Interventions
test group:auricular medicine therapy
control group:take Cetirizine hydrochloride
Sponsors
Tangdu Hospital, China Air Force Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Those who meet the diagnostic criteria of allergic rhinitis and belong to intermittent moderate and severe disease 2.The age range are between 18 – 65 years old 3.Patients with no serious cardiovascular, cerebrovascular, liver, kidney, hematopoietic system diseases or systemic failure, no diabetes, malignancy, mental illness, no connective tissue disease, hemophilia, and bleeding tendency 4.Patients who have not received any Chinese and Western medicine treatment measures in the past 2 weeks 5.Those who voluntarily receive treatment under this protocol and sign the patient informed consent form
Exclusion criteria
Exclusion criteria: 1.Patients with allergic rhinitis in non-attack periods; 2.People who must take anti-allergic drugs due to other allergic diseases, such as allergic asthma; 3.Women who are breastfeeding, pregnant, or preparing for pregnancy; 4.Patients with severe nasal polyps, nasal septal deviation and other need surgical correction; 5.People with serious skin diseases or ulcers localized in the auricle; 6.Allergic to vaccaria seedtape, alcohol, and cetirizine hydrochloride.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The quality of life questionnaire in nasal conjunc;Score of rhinitis symtoms;Score of rhinitis signs; | — |
Countries
China
Contacts
Public ContactLi Xinhong
Department of General Medicine,Tangdu Hospital, Xi’an, China Air Force Medical University
Outcome results
None listed